Anti-Human FVIIa Mutant Version (Vatreptacog alfa) Recombinant Antibody (4F5) (HY060033)

Name: Anti-Human FVIIa Mutant Version (Vatreptacog alfa) Recombinant Antibody (4F5)
Brand: abinScience
SKU: HY060033
Price: 196 USD
Availability: InStock

Datasheet Share product Copy info

Price(USD):

Spec:

50ug
100ug
1mg

Number:

Get quote

Overview
Images
References
Datasheet
SDS

Overview

Catalog No.

HY060033

Species reactivity

Human

Applications

ELISA, FuncS, SPR

Host species

Mouse

Isotype

IgG2a, kappa

Clone ID

4F5

Clonality

Monoclonal

Target

F7, Coagulation factor VII, FVII, Proconvertin, Serum prothrombin conversion accelerator, SPCA, Eptacog alfa, mutant version of FVIIa, FVIIaDVQ, Vatreptacog alfa, hFVIIa, rFVIIa analog NN1731

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P08709

RRID

Anti-Human FVIIa Mutant Version (Vatreptacog alfa) Antibody (4F5) (abinScience Cat# HY060033, RRID:AB_3727168)

Form

Liquid

Storage buffer

0.01M PBS pH 7.4

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Product Usage Information

Application	Dilution
ELISA	1:2000-1:20000

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternate Names

Vatreptacog alfa

Background

Coagulation factor VII (FVIIa Mutant Version (FVIIaDVQ)) is a ~51 kDa protein. Initiates the extrinsic pathway of blood coagulation. Serine protease that circulates in the blood in a zymogen form. Factor VII is converted to factor VIIa by factor Xa, factor XIIa, factor IXa, or thrombin by minor proteolysis. In the presence of tissue factor and calcium ions, factor VIIa then converts factor X to factor Xa by limited proteolysis. Factor VIIa also converts factor IX to factor IXa in the presence of tissue factor and calcium.

1. Osterud, B. et al. (1977) Proceedings of the National Academy of Sciences of the United States of America 74, 5260-4. PMID: 271951

Note

For research use only.

Images

SDS-PAGE

SDS-PAGE for Anti-Human FVIIa Mutant Version (Vatreptacog alfa) Antibody (4F5)

References

Datasheet

Anti-Human FVIIa Mutant Version (Vatreptacog alfa) Recombinant Antibody (4F5).pdf

Download SDS PDF

Formula

Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)

Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.

Mass

Concentration

Volume

Molecular Weight *

g/mol

Formula

C₁ × V₁ = C₂ × V₂

Enter any 3 of the 4 values to solve for the unknown.

Stock Solution

C₁ (Stock Conc.)

V₁ (Stock Vol.)

Working Solution

C₂ (Working Conc.)

V₂ (Working Vol.)

Recombinant Proteins

Antibodies

Assay Kits

Anti-Human FVIIa Mutant Version (Vatreptacog alfa) Recombinant Antibody (4F5) (HY060033)

Overview

Images

References

Datasheet

SDS

Quick access

Contact Us